Company News in the Life Science Industry

»

Reset 

Medix Medical Monitor Survey Uncovers Singapore's Health Concerns and Perceptions

Survey shows high fear of cancer, heart attacks and diabetes, with many Singaporeans pessimistic about their health status and unsure of the best place to turn for advice. Demand for personal medical case management, new cancer treatment technologies and personalised diagnosis is high across... Read more ››

By: PR Newswire Association LLC. - 25 Sep 2018

Anaeropharma Science Signs Collaborative Research Agreement with Astellas on Creation of Novel Anti-Tumor Drugs Using Bifidobacterium

TOKYO, Sept. 25, 2018 /PRNewswire/ -- Anaeropharma Science Inc. headquartered in Tokyo (hereafter "Anaeropharma") announced on September 25 that Anaeropharma and Astellas Pharma Inc. headquartered in Tokyo (hereafter "Astellas") have concluded a collaborative research agreement concerning the... Read more ››

By: PR Newswire Association LLC. - 25 Sep 2018
Related companies:  Anaeropharma Science, Inc.

BLINCYTO® (blinatumomab) Approved In Japan For The Treatment Of Relapsed Or Refractory B-cell Acute Lymphoblastic Leukemia

THOUSAND OAKS, Calif., Sept. 24, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Japanese Ministry of Health, Labour and Welfare has granted marketing approval for BLINCYTO(® )(blinatumomab) for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia... Read more ››

By: PR Newswire Association LLC. - 25 Sep 2018
Related companies:  Amgen, Inc.

Okayama University Research: Insights Into Mechanisms Governing the Resistance to the Anti-Cancer Medication Cetuximab

OKAYAMA, Japan, September 25, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 25 Sep 2018

Ceribell Announces Completion Of $35 Million Series B Financing

MOUNTAIN VIEW, Calif., Sept. 25, 2018 /PRNewswire/ -- Ceribell, Inc. announced today that the company has completed a $35 million Series B financing led by new investors Optimas Capital Partners Fund and The Rise Fund with participation by UCB and LivaNova.

Read more ››
By: PR Newswire Association LLC. - 25 Sep 2018

Atox Bio Announces Independent Safety Monitoring Committee Recommendation to Continue Phase 3 Study of Reltecimod in Necrotizing Soft Tissue Infections

CHAPEL HILL, North Carolina and NESS ZIONA, Israel, September 25, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 25 Sep 2018
Related companies:  Atox Bio Inc.

WuXi Biologics Appoints Harvard Professor David R. Liu to Scientific Advisory Board

SHANGHAI, Sept. 25, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, today announced the appointment of David R. Liu, Professor of Chemistry and... Read more ››

By: PR Newswire Association LLC. - 25 Sep 2018
Related companies:  WuXi Biologics, Ltd. | WuXi Biologics

New Trial Data: Senzer's Inhaler Delivers Cannabinoids Faster at Lower Doses

LONDON, September 25, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 25 Sep 2018

Global Intragastric Balloons Market 2018-2022

NEW YORK, Sept. 24, 2018 /PRNewswire/ -- About Intragastric Balloons

Intragastric balloon, also known as stomach balloon, is an inflatable medical device, which is temporarily placed into the stomach to reduce weight. It limits the amount of food the stomach can hold and causes... Read more ››

By: PR Newswire Association LLC. - 25 Sep 2018

The global radiopharmaceuticals/nuclear medicine market size is expected to reach USD 15.2 billion by 2025

NEW YORK, Sept. 24, 2018 /PRNewswire/ -- Read the full report: https://www.reportlinker.com/p05568394

Read more ››
By: PR Newswire Association LLC. - 25 Sep 2018

Med-X, Inc. and Nature-Cide Sign Leading Pest Control Company Pestmaster Services to Direct Distribution Deal

LOS ANGELES, Sept. 24, 2018 /PRNewswire/ -- Med-X, Inc.'s ("Med-X") green pesticide product division, Nature-Cide, announced today that it has signed a direct distribution deal with one of the nation's leading green-focused pest control service companies, Pestmaster Services. Pestmaster Services,... Read more ››

By: PR Newswire Association LLC. - 25 Sep 2018

Astellas Farma Brasil named one of the best companies to work for in Brazil

SÃO PAULO, Sept. 24, 2018 /PRNewswire/ -- Astellas Farma Brasil (AFB) was recently named one of the Best Pharmaceutical Companies To Work For in Brazil according to Great Place to Work(®) Institute's latest ranking. This marks the fifth consecutive year AFB has been recognized as a top pharmaceutical... Read more ››

By: PR Newswire Association LLC. - 24 Sep 2018
Related companies:  Astellas Pharma Inc.

CAP Statement on US District Court Opinion on Lawsuit Against HHS

WASHINGTON, Sept. 24, 2018 /PRNewswire/ -- College of American Pathologists (CAP) President R. Bruce Williams, MD, FCAP issued the following statement after the U.S. District Court for the District of Columbia in American Clinical Laboratory Association (ACLA) v Azar:

Read more ››
By: PR Newswire Association LLC. - 24 Sep 2018

European and U.S. Patent Allowances Strengthen Immunexpress' Leading Position in Host-Response Sepsis Diagnostics

SEATTLE, Sept. 24, 2018 /PRNewswire/ -- Immunexpress, Inc., today announced the receipt of 'Notices of Allowance' from both the U.S. Patent and Trademark Office (USPTO) and the European Patent Office for the patent entitled "Biomarker identification" (U.S. Application No. 14/90012, EPO... Read more ››

By: PR Newswire Association LLC. - 24 Sep 2018
Related companies:  IMMUNEXPRESS INC.

Global Automated Biochemistry Analyzers Market 2018-2022 - Increasing Use of Biochemical Tests for Pregnancy-Related Issues

DUBLIN, Sept 24, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 24 Sep 2018

Game Changing Tuberculosis Assay Validated for Illumina's MiSeq® Platform

Next Generation Sequencing (NGS) Kit to Improve Speed and Accuracy of M. Tuberculosis (MTB) Drug Sensitivity Testing (DST) at a Fraction of the Current Cost of Sequencing

Read more ››
By: PR Newswire Association LLC. - 24 Sep 2018
Related companies:  Longhorn Vaccines and Diagnostics LLC.

Arena Pharmaceuticals Reports Positive Phase 2a Results for Olorinab in Patients with Abdominal Pain Associated with Crohn's Disease

SAN DIEGO, Sept. 24, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced positive topline results from its Phase 2a trial of olorinab, an investigational, peripherally restricted, highly selective, full agonist... Read more ››

By: PR Newswire Association LLC. - 24 Sep 2018
Related companies:  Arena Pharmaceuticals, Inc.

Heron Therapeutics to Present at the 2018 Cantor Global Healthcare Conference

SAN DIEGO, Sept. 24, 2018 /PRNewswire/ -- Heron Therapeutics, Inc. (NASDAQ: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, announced that Barry D. Quart,... Read more ››

By: PR Newswire Association LLC. - 24 Sep 2018
Related companies:  Heron Therapeutics, Inc.

Syndax Announces Updated Results from Phase 2 ENCORE 601 Trial of Entinostat in Combination with KEYTRUDA® (pembrolizumab) in Non-Small Cell Lung Cancer

WALTHAM, Mass., Sept. 24, 2018 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced updated results from the ongoing ENCORE 601 cohort enrolling... Read more ››

By: PR Newswire Association LLC. - 24 Sep 2018
Related companies:  Syndax Pharmaceuticals, Inc.

Ionis Announces the Appointment of Two New Board Members

CARLSBAD, Calif., Sept. 24, 2018 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in antisense therapeutics, today announced the appointment of two new members to its Board of Directors effective immediately - Dr. Michael Hayden, Killam Professor at the University of British... Read more ››

By: PR Newswire Association LLC. - 24 Sep 2018
Related companies:  Ionis Pharmaceuticals, Inc.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies